Reduced Glutathione for Injection

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: for Injection
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory & Trading Company

360° Virtual Tour

Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
4950
Management System Certification
ISO9001:2015, ISO14001:2015, OHSAS18001:2007, GMP, GMP, GMP, GMP, GMP, GMP
  • Reduced Glutathione for Injection
  • Reduced Glutathione for Injection
  • Reduced Glutathione for Injection
  • Reduced Glutathione for Injection
Find Similar Products

Basic Info.

Suitable for
Elderly, Children, Adult
State
Solid
Shape
Powder
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Transport Package
1/10/50vial/box
Specification
0.3g/0.6g/1.2g
Trademark
Reyoung
Origin
China

Product Description

Reduced Glutathione for Injection

  Reduced glutathione for injection is used to prevent and treat tissue and cell damage caused by drugs [such as chemotherapy drugs, antituberculosis drugs, psychoneurology drugs, paracetamol, etc.), radiotherapy, alcohol and organophosphorus, etc.; it has protective effect on liver injury caused by various reasons.
  It is also found in many kinds of cytoplasmic substances, such as glutathione, glutathione and glutathione. The sulfhydryl group of cysteine in reduced glutathione is highly nucleophilic, so it is the main target structure of electrophiles excited by xenobiotics or their metabolites, thus protecting the main nucleophilic sites. If the latter is affected, it will lead to cell damage. Once it reacts with organic oxidative metabolites, it can form low toxicity compounds which are easy to metabolize. The level of intracellular glutathione changes and the concentration decreases in many cases such as malnutrition, various diseases, chemical poisoning and drug administration. In animals and humans, reduced glutathione has protective effects on cytotoxicity induced by many substances such as salicylic acid, organophosphorus insecticides and alcohol. In vivo studies have shown that reduced glutathione does not affect intestinal dynamics, blood pressure and respiration, and does not cause ECG changes.
  Toxicological study
  Acute toxicity test: intravenous infusion of glutathione sodium salt at the dose of 1000mg / kg will not cause death of rats and mice. Rabbits could tolerate the dose of 3000mg / kg. Intraperitoneal administration of 7500mg / kg did not cause death in rats and mice.
  Repeated dose toxicity test: glutathione sodium salt was infused intravenously at the daily doses of 500mg / kg / D and 1000mg / kg / D for 28 consecutive days without any pathological changes in rabbits. Glutathione sodium salt was administered intraperitoneally at the doses of 4386 mg / kg / day and 129 mg / kg / day for 90 consecutive days without any pathological symptoms or abnormal histological and biochemical parameters.
  Teratogenicity test: glutathione salt was given to Wistar mice and New Zealand rabbits at the dose of 86 mg / kg / day, which did not affect the reproduction, growth and lactation of newborn animals.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier